A4. Treatment of antimicrobial resistant infections
Poster Session: Treatment of Antimicrobial-Resistant Infections
Yehuda Carmeli, MD
Professor of Medicine, Head of the Israeli National Center for Antibiotic Resistance, Chief of the Division of Epidemiology
Israel Ministry of Health
Tel Aviv, Tel Aviv, Israel
Mark A. Price, MA, MEd
Head, Economic Qualitative Inquiry, Policy, and Access
RTI Health Solutions
Pittsboro, North Carolina, United States
George L. Daikos, MD
National and Kapodistrian University of Athens
Athens, Attiki, Greece
Marco Falcone, MD
Sapienza University of Rome
Rome, Lazio, Italy
Ana C. Gales, MD
Full professor of Infectious Diseases
UNIFESP
SAO PAULO, Sao Paulo, Brazil
Stefen Hagel, MD
Jena University Hospital
Jena, Thuringen, Germany
Ali S. Omrani, FRCP, FRCPath
Qatar University College of Medicine, Hamad General Hospital
Doha, Al Wakrah, Qatar
Paula Ramirez Galleymore, PhD
La Fe University and Polytechnic Hospital
Valencia, Comunidad Valenciana, Spain
Subhash Todi, MBBS, MD, MRCP
Manipal Hospital
Dhakuria, West Bengal, India
Minggui Wang, MD
Professor
Institute of Antibiotics, Huashan Hospital, Fudan University
Shanghai, Shanghai, China (People's Republic)
Maria Gheorghe, PhD
Pfizer Inc.
Bucharest, Bucuresti, Romania
Brett Hauber, PhD
Pfizer, Inc.
New York, New York, United States
Christopher Little, PhD
Pfizer Inc.
Tadworth, England, United Kingdom
Andrew Ian Townsend, PhD
Pfizer Inc.
Tadworth, England, United Kingdom
Nathalie Baillon-Plot, MD
Pfizer Inc.
Paris, Ile-de-France, France